vs
Side-by-side financial comparison of FRESH DEL MONTE PRODUCE INC (FDP) and Insulet Corporation (PODD). Click either name above to swap in a different company.
FRESH DEL MONTE PRODUCE INC is the larger business by last-quarter revenue ($1.0B vs $783.7M, roughly 1.3× Insulet Corporation). Insulet Corporation runs the higher net margin — 13.0% vs 3.2%, a 9.8% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 0.6%). Insulet Corporation produced more free cash flow last quarter ($48.2M vs $-17.2M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs -4.1%).
Fresh Del Monte Produce Incorporated is one of the world’s leading vertically integrated producers, distributors, and marketers of prepared, fresh and fresh-cut fruits and vegetables. Incorporated in George Town, Cayman Islands, its US executive office is located at 241 Sevilla Avenue, Coral Gables, Florida.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
FDP vs PODD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.0B | $783.7M |
| Net Profit | $32.3M | $101.6M |
| Gross Margin | 10.4% | 72.6% |
| Operating Margin | 4.5% | 18.7% |
| Net Margin | 3.2% | 13.0% |
| Revenue YoY | 0.6% | 31.2% |
| Net Profit YoY | 59.1% | 0.9% |
| EPS (diluted) | $0.67 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.0B | $783.7M | ||
| Q3 25 | $1.0B | $706.3M | ||
| Q2 25 | $1.2B | $649.1M | ||
| Q1 25 | $1.1B | $569.0M | ||
| Q4 24 | $1.0B | $597.5M | ||
| Q3 24 | $1.0B | $543.9M | ||
| Q2 24 | $1.1B | $488.5M | ||
| Q1 24 | $1.1B | $441.7M |
| Q4 25 | $32.3M | $101.6M | ||
| Q3 25 | $-29.1M | $87.6M | ||
| Q2 25 | $56.8M | $22.5M | ||
| Q1 25 | $31.1M | $35.4M | ||
| Q4 24 | $20.3M | $100.7M | ||
| Q3 24 | $42.1M | $77.5M | ||
| Q2 24 | $53.6M | $188.6M | ||
| Q1 24 | $26.1M | $51.5M |
| Q4 25 | 10.4% | 72.6% | ||
| Q3 25 | 7.9% | 72.2% | ||
| Q2 25 | 10.2% | 69.7% | ||
| Q1 25 | 8.4% | 71.9% | ||
| Q4 24 | 6.8% | 72.1% | ||
| Q3 24 | 9.2% | 69.3% | ||
| Q2 24 | 9.9% | 67.7% | ||
| Q1 24 | 7.4% | 69.5% |
| Q4 25 | 4.5% | 18.7% | ||
| Q3 25 | -2.1% | 16.7% | ||
| Q2 25 | 5.8% | 18.7% | ||
| Q1 25 | 4.1% | 15.6% | ||
| Q4 24 | 3.0% | 18.3% | ||
| Q3 24 | 5.3% | 16.2% | ||
| Q2 24 | 6.0% | 11.2% | ||
| Q1 24 | 4.0% | 12.9% |
| Q4 25 | 3.2% | 13.0% | ||
| Q3 25 | -2.8% | 12.4% | ||
| Q2 25 | 4.8% | 3.5% | ||
| Q1 25 | 2.8% | 6.2% | ||
| Q4 24 | 2.0% | 16.9% | ||
| Q3 24 | 4.1% | 14.2% | ||
| Q2 24 | 4.7% | 38.6% | ||
| Q1 24 | 2.4% | 11.7% |
| Q4 25 | $0.67 | $1.42 | ||
| Q3 25 | $-0.61 | $1.24 | ||
| Q2 25 | $1.18 | $0.32 | ||
| Q1 25 | $0.64 | $0.50 | ||
| Q4 24 | $0.41 | $1.38 | ||
| Q3 24 | $0.88 | $1.08 | ||
| Q2 24 | $1.12 | $2.59 | ||
| Q1 24 | $0.55 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $35.7M | — |
| Total DebtLower is stronger | $176.2M | $930.8M |
| Stockholders' EquityBook value | $2.0B | $1.5B |
| Total Assets | $3.1B | $3.2B |
| Debt / EquityLower = less leverage | 0.09× | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.7M | — | ||
| Q3 25 | $97.2M | — | ||
| Q2 25 | $85.5M | — | ||
| Q1 25 | $34.4M | — | ||
| Q4 24 | $32.6M | — | ||
| Q3 24 | $50.8M | — | ||
| Q2 24 | $37.8M | — | ||
| Q1 24 | $42.2M | — |
| Q4 25 | $176.2M | $930.8M | ||
| Q3 25 | $176.7M | $934.9M | ||
| Q2 25 | $205.2M | $939.0M | ||
| Q1 25 | $237.4M | $1.6B | ||
| Q4 24 | $248.9M | $1.3B | ||
| Q3 24 | $274.8M | $1.4B | ||
| Q2 24 | $290.4M | $1.4B | ||
| Q1 24 | $405.8M | $1.4B |
| Q4 25 | $2.0B | $1.5B | ||
| Q3 25 | $2.0B | $1.4B | ||
| Q2 25 | $2.1B | $1.5B | ||
| Q1 25 | $2.0B | $1.3B | ||
| Q4 24 | $2.0B | $1.2B | ||
| Q3 24 | $2.0B | $1.1B | ||
| Q2 24 | $2.0B | $998.4M | ||
| Q1 24 | $1.9B | $790.7M |
| Q4 25 | $3.1B | $3.2B | ||
| Q3 25 | $3.1B | $3.0B | ||
| Q2 25 | $3.2B | $3.5B | ||
| Q1 25 | $3.2B | $3.5B | ||
| Q4 24 | $3.1B | $3.1B | ||
| Q3 24 | $3.2B | $3.0B | ||
| Q2 24 | $3.1B | $2.9B | ||
| Q1 24 | $3.2B | $2.6B |
| Q4 25 | 0.09× | 0.61× | ||
| Q3 25 | 0.09× | 0.68× | ||
| Q2 25 | 0.10× | 0.64× | ||
| Q1 25 | 0.12× | 1.21× | ||
| Q4 24 | 0.13× | 1.07× | ||
| Q3 24 | 0.14× | 1.21× | ||
| Q2 24 | 0.15× | 1.36× | ||
| Q1 24 | 0.21× | 1.72× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.9M | $183.3M |
| Free Cash FlowOCF − Capex | $-17.2M | $48.2M |
| FCF MarginFCF / Revenue | -1.7% | 6.2% |
| Capex IntensityCapex / Revenue | 2.8% | 17.2% |
| Cash ConversionOCF / Net Profit | 0.34× | 1.80× |
| TTM Free Cash FlowTrailing 4 quarters | $181.3M | $377.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.9M | $183.3M | ||
| Q3 25 | $75.0M | $125.7M | ||
| Q2 25 | $113.1M | $196.5M | ||
| Q1 25 | $46.1M | $63.8M | ||
| Q4 24 | $-4.7M | $147.7M | ||
| Q3 24 | $43.5M | $98.5M | ||
| Q2 24 | $125.0M | $96.5M | ||
| Q1 24 | $18.7M | $87.6M |
| Q4 25 | $-17.2M | $48.2M | ||
| Q3 25 | $60.9M | $100.1M | ||
| Q2 25 | $101.5M | $177.9M | ||
| Q1 25 | $36.1M | $51.5M | ||
| Q4 24 | $-22.3M | $94.1M | ||
| Q3 24 | $30.1M | $71.8M | ||
| Q2 24 | $117.0M | $74.0M | ||
| Q1 24 | $6.0M | $65.5M |
| Q4 25 | -1.7% | 6.2% | ||
| Q3 25 | 6.0% | 14.2% | ||
| Q2 25 | 8.6% | 27.4% | ||
| Q1 25 | 3.3% | 9.1% | ||
| Q4 24 | -2.2% | 15.7% | ||
| Q3 24 | 3.0% | 13.2% | ||
| Q2 24 | 10.3% | 15.1% | ||
| Q1 24 | 0.5% | 14.8% |
| Q4 25 | 2.8% | 17.2% | ||
| Q3 25 | 1.4% | 3.6% | ||
| Q2 25 | 1.0% | 2.9% | ||
| Q1 25 | 0.9% | 2.2% | ||
| Q4 24 | 1.7% | 9.0% | ||
| Q3 24 | 1.3% | 4.9% | ||
| Q2 24 | 0.7% | 4.6% | ||
| Q1 24 | 1.1% | 5.0% |
| Q4 25 | 0.34× | 1.80× | ||
| Q3 25 | — | 1.43× | ||
| Q2 25 | 1.99× | 8.73× | ||
| Q1 25 | 1.48× | 1.80× | ||
| Q4 24 | -0.23× | 1.47× | ||
| Q3 24 | 1.03× | 1.27× | ||
| Q2 24 | 2.33× | 0.51× | ||
| Q1 24 | 0.72× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FDP
| Other | $482.7M | 47% |
| Gold Pineapples | $184.9M | 18% |
| Fresh Cut Fruit | $126.4M | 12% |
| Fresh Cut Vegetables | $69.3M | 7% |
| Avocados | $66.9M | 7% |
| Other Fruit Productsand Services | $26.1M | 3% |
| Non Tropical Fruit | $23.0M | 2% |
| Melons | $20.6M | 2% |
| Vegetables | $19.6M | 2% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
